Work

Sorafenib plus daily low-dose temozolomide for relapsed glioblastoma: a phase II study.

Year: 2013

Type: article

Study design: Clinical Trial

Source: PubMed

Authors: Fable Zustovich, Lorenza Landi, Giuseppe Lombardi, Camillo Porta, Luca Galli, Andrea Fontana, Domenico Amoroso, Costanza Galli, Michele Andreuccetti, Alfredo Falcone, Vittorina Zagonel

Institutions: Istituto Oncologico Veneto, Ospedale di Livorno, Policlinico San Matteo Fondazione, Azienda Ospedaliera Universitaria Pisana, Ospedale Versilia

Language: English

Topic: Glioma Diagnosis and Treatment

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2279599902

FWCI: 4.301

Cites: 39

Cited by: 68

Related to: 10